A23_-_Protection_of_Human_Subjects_Assurance_Identification.pdf

PDF 151 KB Posted

Attached to
Request for Proposals - Phase I Clinical Trials Federal contract opportunity
Solicitation number
75N95024R00086
Issued by
Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse

About this file

This document is a Protection of Human Subjects Assurance Identification/IRB Certification/Declaration of Exemption form. It describes the policy and requirements for conducting or supporting research activities involving human subjects under the Common Rule. The form requires the institution to certify that proposed research has been reviewed and approved by an Institutional Review Board (IRB), and provides options for declaring exemption status or indicating that no assurance has been filed. The form also includes sections for identifying the federal department/agency, research activity title, principal investigator, and assurance status, as well as certification of IRB review and approval. This form would be required to be submitted with any application or proposal for federal research funding involving human subjects.

The related federal contract opportunity is a Request for Proposals for Phase I Clinical Trials for the development of small molecule and biologic therapeutics. The solicitation was issued by the Department of Health and Human Services, National Institutes of Health, National Institute on Drug Abuse. No other details about the contract opportunity are provided in the given information.

View the file

Other files for this federal contract opportunity

Other files attached to Request for Proposals - Phase I Clinical Trials, newest first.
File Type Posted
RFP_75N95024R00086_Amnd_0003_0003.pdf PDF
Sol_75N95024R00086_Amd_0003.pdf PDF
RFP_75N95024R00086_Amnd_0002_0002.pdf PDF
Sol_75N95024R00086_Amd_0002.pdf PDF
Sol_75N95024R00086_Amd_0001.pdf PDF
A15_-_SBCX_Industry_Subcontracting_Guide.pdf PDF
A3_-_Proposal_Intent_Response_Form.pdf PDF
A22_-_PHS_Human_Subjects_and_Clinical_Trials_Information_Form-H.pdf PDF
A7_-_IDIQ_Contract_Statement_of_Work__080724.pdf PDF
A10_-_Sample_TORFP_3_SOW_-_SADMAD_Study_080624.pdf PDF
A12_-_Summary_of_Related_Activities.pdf PDF
A9_-_Sample_TORFP_2_SOW_-_SAD_Study_080624.pdf PDF
A18_-_DEC_Acknowledgment.pdf PDF
Sol_75N95024R00086.pdf PDF
A11_-_Additional_Technical_Proposal_Instructions.pdf PDF
A19_-_NIH(RC)-1_-_Invoice_Financing_Request_Instructions.pdf PDF
A1_-_RFP_Cover_Letter_081924_signed.pdf PDF
A16_-_Wage_Determination.pdf PDF
A4_-_Proposal_Summary_and_Data_Record__NIH-2043.pdf PDF
A13_-_Technical_Proposal_Cost_Summary.pdf PDF
A5_-_Offeror_s_Points_of_Contact.pdf PDF
A20_-_NIDA_Supplemental_Billing_Instructions.pdf PDF
A14_-_Breakdown_of_Proposed_Estimated_Costs.xlsx XLSX spreadsheet
A2_-_Packaging_and_Delivery_of_Proposals_for_Use_with_the_NIH_eCPS_website.pdf PDF
A8_-_Sample_TORFP_1_SOW_-_Kickoff_Meeting_PMP.pdf PDF
A24_-_Public_Health_Surveillance_Exclusion_Request.pdf PDF
A17_-_Disclosure_of_Lobbying_Activities__OMB_Form_SF-LLL.pdf PDF
A6_-_Section_K_-_Representations__Certifications__and_Other_Statements_of_Offerors_May_2024.docx DOCX document
A21_-_NIH(RC)-2_-_Fixed-Price_Invoice_Instructions.pdf PDF
Show all 29

On GovTribe

Work with this file on GovTribe

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

OMB No. 0990-0263 Approved for use through June 30, 2024

Protection of Human Subjects Assurance Identification/IRB Certification/Declaration of Exemption (Common Rule)

Policy: Research activities involving human subjects may not be conducted or supported by the Departments and Agencies adopting the Common Rule unless the activities are exempt from or approved in accordance with the Common Rule. The “pre-2018 Common Rule (or pre-2018 Requirements)” was originally promulgated in 1991 and amended on June 23, 2005 (70 FR 36325). The “2018 Common Rule (or 2018 Requirements)” was originally published on January 19, 2017 (82 FR 7149) and amended on January 22, 2018 (83 FR 2885) and June 19, 2018 (83 FR 28497). The categories of exempt research are provided in Section 101(b) of the pre-2018 Common Rule and Section 104(d) of the 2018 Common Rule.

The pre-2018 Common Rule requires institutions to certify that each application or proposal for research has been reviewed and approved by an Institutional Review Board (IRB) (Section 103(f)). The 2018 Common Rule requires institutions to certify that each proposed research study has been reviewed and approved by an IRB (Section 103(d)). Institutions must have an assurance of compliance that applies to the research to be conducted and should submit certification of IRB review and approval with each application or proposal, or proposed research study, unless otherwise advised by the Department or Agency.

1. Request Type

[ ] ORIGINAL

[ CONTINUATION

[ ] EXEMPTION

2. Type of Mechanism

[ ] GRANT

[ ] CONTRACT

[ ] FELLOWSHIP

[ ] COOPERATIVE

AGREEMENT

[ ] OTHER:

3. Name of Federal Department or Agency and, if known, Application or Proposal Identification No.

4. Title of Application or Activity 5. Name of Principal Investigator, Program Director, Fellow, or Other

6. Assurance Status of this Project (Respond to one of the following)

[ ] This Assurance, on file with the Department of Health and Human Services, covers this activity:

Assurance Identification No. , the expiration date IRB Registration No.

[ ] This Assurance, on file with (agency/dept) , covers this activity.

Assurance No. , the expiration date IRB Registration/Identification No. (if applicable)

[ ] No assurance has been filed for this institution. This institution declares that it will provide an Assurance and Certification of IRB review and approval upon request.

[ ] Exemption Status: Human subjects are involved, but this activity qualifies for exemption under the pre-2018 Common Rule, Section 101(b), paragraph .

[ ] Exemption Status: Human subjects are involved, but this activity qualifies for exemption under the 2018 Common Rule, Section 104(d), paragraph

7. Certification of IRB Review (Respond to one of the following IF you have an Assurance on file)

[ ] This activity has been reviewed and approved by the IRB in accordance with the Common Rule and any other governing regulations.

by:

[ ] Full IRB Review on (date of IRB meeting) or [ ] Expedited Review on (date)

[ ] If less than one year approval, provide expiration date

[ ] This activity contains multiple projects, some of which have not been reviewed. The IRB has granted approval on condition that all projects covered by the Common Rule will be reviewed and approved before they are initiated and that appropriate further certification will be submitted.

8. Comments

9. The official signing below certifies that the information provided above is correct and that, as required, future reviews will be

10. Name and Address of Institution performed until study closure and certification will be provided.

11. Phone No. (with area code)

12. Email:

13. Name of Official

14. Title

15. Signature

16. Date

Authorized for local Reproduction

Sponsored by HHS

According to the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number. The valid OMB control number for this information collection is 0990-0263. The time required to complete this information collection is estimated to average 30 minutes per response. If you have comments concerning the accuracy of the time estimate(s) or suggestions for improving this form, please write to: U.S. Department of Health & Human Services, OS/OCIO/PRA, 200 Independence Ave., S.W., Suite 336-E, Washington D.C. 20201, Attention: PRA Reports Clearance Officer.

File details come from the government source that posted it. Updated .